laninamivir: Clinical Trials

5 trials of laninamivir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 terminated. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Phase 23Completed 1, Recruiting 1, Terminated 1

Follow laninamivir: new trials by email Literature Review of laninamivir trials Research Report on laninamivir

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza
Oseltamivir, Favipiravir, Zanamivir - Influenza, Influenza, Human
Phase 2RecruitingUniversity of Oxford30002023-02-222026-04-14
Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza
20 mg laninamivir octanoate, Placebo, 40 mg laninamivir octanoate - Influenza
Phase 1 / Phase 2TerminatedBiota Scientific Management Pty Ltd152013-11-012025-01-13
Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma
Laninamivir octanoate - Asthma
Phase 1CompletedBiota Scientific Management Pty Ltd322013-10-012018-05-30
Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza
40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate, Placebo - Influenza
Phase 2CompletedBiota Scientific Management Pty Ltd6392013-05-012018-05-31
Safety, Tolerability and Pharmacokinetic Study of Multiple Doses of CS-8958
CS-8958, Placebo - Influenza
Phase 1CompletedBiota Scientific Management Pty Ltd162009-04-012018-05-30

Conditions studied

Influenza, Human (4)  ·  Asthma (1)  ·  Lymphoma, Follicular (1)

Sponsors

Biota Scientific Management Pty Ltd (4)  ·  University of Oxford (1)

Countries

United Kingdom (3)  ·  United States (2)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Colombia (1)  ·  Estonia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Laos (1)  ·  Latvia (1)  ·  Mexico (1)

Top investigators

Jolanta Airey, Dr (2)  ·  Jane Ryan, PhD (1)  ·  John Lambert, PhD (1)

Results publications

PMID 42520824

NIH funding

1UC1AI062373-01 (1), 2008 (1)